Drugmakers could find sympathetic US Supreme Court in drug pricing lawsuits

Drugmakers challenging a Biden
administration program requiring them to negotiate with Medicare
over the prices of selected costly drugs may not have a clear
legal precedent on their side, but there...

Related Keywords

California ,United States ,New York ,San Francisco ,Americans ,Amy Stevens ,James Blumstein ,Joe Biden ,America Ph ,Lawrence Gostin ,Robin Feldman ,Brendan Pierson ,Medicaid Services ,Supreme Court ,Astrazeneca ,Bristol Myers Squibb ,Us Chamber ,Us Supreme Court ,University Of California College The Law ,Environmental Protection Agency ,Vanderbilt Law School ,Reuters ,Us Centers For Medicare ,Georgetown Law ,Inflation Reduction Act ,Democratic President Joe Biden ,Pharmaceutical Research ,Affordable Care Act ,California College ,First Amendment ,Reporting By Brendan Pierson ,Bill Berkrot ,Markets ,